Direct Biologics Receives FDA Approval to Initiate ‘EXIT-COVID-19,’ a Phase II Investigational New Drug Trial
Bengaluru, NFAPost: Direct Biologics (LLC) is announcing today that it has received…
Search
Have an existing account?
Sign In
Tag: Phase 2 Investigational New Drug Trial
